Vanguard has reopened Vanguard Primecap following 20 years of limiting new money flowing into it. In the wake of strong client demand, the firm had prudently closed the fund in 2004 to preserve the fund’s ability to invest meaningfully in attractive mid- and small-cap stocks. With an asset base of more than $75 billion, it remains among the world’s biggest mutual funds. But steady redemptions over the years, combined with the investment team’s distaste for rapidly trading or pursuing hot stocks, provide capacity for new investors to buy it. The fund’s Morningstar Medalist Ratings are unchanged.
Vanguard PRIMECAP Inv VPMCX
- NAV / 1-Day Return 173.70 / +0.27 %
- Total Assets 76.1 Bil
-
Adj. Expense Ratio
0.380%
- Expense Ratio 0.380%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Large Blend
- Investment Style Large Growth
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 0.94%
- Turnover 4%
USD | NAV as of Jun 26, 2024 | 1-Day Return as of Jun 26, 2024, 10:21 PM GMT+0
Morningstar’s Analysis VPMCX
Will VPMCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 40.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 12.69 | 9.6 Bil | Healthcare |
Micron Technology Inc | 3.68 | 2.8 Bil | Technology |
Microsoft Corp | 3.42 | 2.6 Bil | Technology |
Amgen Inc | 3.37 | 2.6 Bil | Healthcare |
FedEx Corp | 3.26 | 2.5 Bil | Industrials |
KLA Corp | 3.22 | 2.4 Bil | Technology |
Adobe Inc | 2.85 | 2.2 Bil | Technology |
Intel Corp | 2.69 | 2.0 Bil | Technology |
Biogen Inc | 2.60 | 2.0 Bil | Healthcare |
Texas Instruments Inc | 2.44 | 1.9 Bil | Technology |